HSBC Holdings’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$227K Buy
42,609
+12,085
+40% +$64.4K ﹤0.01% 2156
2025
Q1
$268K Buy
30,524
+310
+1% +$2.72K ﹤0.01% 2001
2024
Q4
$413K Buy
30,214
+9,997
+49% +$137K ﹤0.01% 1891
2024
Q3
$547K Sell
20,217
-7,976
-28% -$216K ﹤0.01% 1608
2024
Q2
$680K Buy
+28,193
New +$680K ﹤0.01% 1512
2023
Q1
Sell
-17,914
Closed -$253K 2403
2022
Q4
$253K Buy
17,914
+5,076
+40% +$71.6K ﹤0.01% 2185
2022
Q3
$255K Sell
12,838
-9,275
-42% -$184K ﹤0.01% 2071
2022
Q2
$408K Sell
22,113
-3,324
-13% -$61.3K ﹤0.01% 2062
2022
Q1
$648K Buy
+25,437
New +$648K ﹤0.01% 1892
2021
Q3
Sell
-15,023
Closed -$454K 2599
2021
Q2
$454K Buy
15,023
+6,060
+68% +$183K ﹤0.01% 1847
2021
Q1
$271K Sell
8,963
-6,676
-43% -$202K ﹤0.01% 2009
2020
Q4
$307K Buy
+15,639
New +$307K ﹤0.01% 2127
2020
Q2
Sell
-10,975
Closed -$157K 2326
2020
Q1
$157K Sell
10,975
-3,064
-22% -$43.8K ﹤0.01% 1958
2019
Q4
$387K Buy
+14,039
New +$387K ﹤0.01% 1861
2019
Q2
Sell
-8,124
Closed -$270K 2174
2019
Q1
$270K Buy
+8,124
New +$270K ﹤0.01% 1877
2018
Q3
Sell
-15,900
Closed -$593K 1959
2018
Q2
$593K Buy
+15,900
New +$593K ﹤0.01% 1479
2017
Q4
Sell
-6,962
Closed -$252K 1912
2017
Q3
$252K Buy
+6,962
New +$252K ﹤0.01% 1551
2017
Q1
Sell
-18,268
Closed -$304K 1929
2016
Q4
$304K Buy
+18,268
New +$304K ﹤0.01% 1789
2015
Q4
Sell
-5,930
Closed -$221K 1749
2015
Q3
$221K Sell
5,930
-487
-8% -$18.2K ﹤0.01% 1579
2015
Q2
$218K Sell
6,417
-778
-11% -$26.4K ﹤0.01% 1557
2015
Q1
$255K Buy
7,195
+907
+14% +$32.1K ﹤0.01% 1520
2014
Q4
$214K Buy
+6,288
New +$214K ﹤0.01% 1361